Feasibility Study with 2 Months of Talazoparib | Tumor Volume Decrease of 88% in 2 Months

Feasibility Study with 2 Months of Talazoparib | Tumor Volume Decrease of 88% in 2 Months

Annual-Meeting

2 years
73 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jennifer K. Litton, MD, MD Anderson Cancer Center, shares Feasibility Study with 2 Months of Talazoparib Tumor Volume Decrease of 88i% n 2 Months at Annual Meeting 2018
Up Next Autoplay